CryoLife has started distributing Hemostase MPH in the US, the UK and Germany in the second quarter of 2008. Distribution will continue to expand to additional markets later in 2008 and in 2009.
Steven Anderson, president and CEO of CryoLife, said: “Hemostase MPH is complementary to our BioGlue surgical adhesive products. It provides surgeons with the ability to quickly and confidently control active bleeding during surgery. We are pleased to be able to offer this product in Canada through the Sorin Group.”